Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age

被引：0

作者：

Raffaele Addeo

Vincenzo Faiola

Rosario Guarrasi

Liliana Montella

Bruno Vincenzi

Elena Capasso

Gregorio Cennamo

Maria Saveria Rotundo

Pierosandro Tagliaferri

Michele Caraglia

Salvatore Del Prete

机构：

[1] “S.Giovanni di Dio” Hospital,Oncology Unit, U.O.C. Oncology

[2] Campus Biomedico University,Section of Oncology

[3] University Magna Grǽcia of Catanzaro and Oncology Center “T. Campanella”,Department of Experimental and Clinical Medicine

[4] National Institute of Tumours of Naples,Experimental Pharmacology Unit, INT Pascale

[5] Via Mariano Semmola,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2008年 / 62卷

关键词：

Metastatic breast cancer; Vinorelbine; Liposomal pegylated doxorubicin; QoL; Elderly patients;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Xin-Ru Li
Xing-Han Cheng
Guo-Nan Zhang
Xiao-Xin Wang
Jian-Ming Huang
Journal of Ovarian Research, 15
[32] Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
Li, Xin-Ru
Cheng, Xing-Han
Zhang, Guo-Nan
Wang, Xiao-Xin
Huang, Jian-Ming
JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
[33] MITOXANTRONE-VINORELBINE AS FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER
FERRERO, JM
PIVOT, X
NAMER, M
WENDLING, JL
FRENAY, M
FRANCOIS, E
HOCH, M
TEISSIER, E
BULLETIN DU CANCER, 1995, 82 (03) : 202 - 207
[34] Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer
Ingle, JN
Krook, JE
Mailliard, JA
Hartmann, LC
Wieand, HS
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 498 - 501
[35] Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer
Baltali, E
Altundag, MK
Güler, N
Özisik, Y
Firat, D
Baran, I
Tekuzman, G
TUMORI, 2002, 88 (03) : 200 - 203
[36] PRESERVED ANTITUMOR ACTIVITY AND REDUCED CARDIOTOXICITY OF FIRST-LINE PEGYLATED LIPOSOMAL DOXORUBICIN COMPARED WITH CONVENTIONAL DOXORUBICIN IN PATIENTS WITH METASTATIC BREAST CANCER
Mann, K.
Rana, C.
Wadhwa, A.
VALUE IN HEALTH, 2010, 13 (07) : A251 - A251
[37] Pilot study with pegylated liposomal doxorubicin (PLD) and docetaxel as first-line treatment in patients with metastatic breast cancer (MBC)
Mel, J. R., Sr.
Ramos, M.
Cueva, J.
Castellanos, J.
Almanza, C.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[38] VINORELBINE AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CARCINOMA
ROMERO, A
RABINOVICH, MG
VALLEJO, CT
PEREZ, JE
RODRIGUEZ, R
CUEVAS, MA
MACHIAVELLI, M
LACAVA, JA
LANGHI, M
ACUNA, LR
AMATO, S
BARBIERI, R
SABATINI, C
LEONE, BA
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) : 336 - 341
[39] Phase I/II Gemcitabine (G) with Pegylated Liposomal Doxorubicin (PLD) as first-line therapy in metastatic breast cancer (MBC) in Asian women
Wong, Zee Wan
Shah, Valencia A.
Wong, Nan Soon
Ang, Peter Cher Siang
Silverman, Carrie
Tan, Say Beng
Cheung, Yin Bun
Chowbay, Balram
See, Hui Ti
Khoo, Kei Siong
ANNALS OF ONCOLOGY, 2004, 15 : 43 - 43
[40] Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer
Lawrie, Theresa A.
Rabbie, Roy
Thoma, Clemens
Morrison, Jo
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10):

← 1 2 3 4 5 →